SEC Form D · filed May 3, 2024
Endeavor Biomedicines, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
John Hood · San Diego, CAExec · DirectorMonal C. Mehta · San Diego, CADirectorMiguel De Los Rios · San Diego, CAExecBernard Davitian · San Diego, CADirectorPatrick G. Enright · San Diego, CADirectorWing C. Lam · San Diego, CADirectorKaran C. Takhar · San Diego, CADirectorPhilip Dickie · Grand Cayman, Cayman IslandsDirectorJonathan Gazdak · Tampa, FLDirectorTodd Underwood · Portland, ORExecAndrew C. Hakim · GRAND RAPIDS, MIExec · DirectorDaniel H. Shuart · GRAND RAPIDS, MIDirectorMatthew P. Franz · GRAND RAPIDS, MIDirectorVishaal Turakhia · San Diego, CAExecChris Krueger · San Francisco, CAExecEnoch Kariuki · San Diego, CAExecAlex Ruggieri · Vancouver, British Columbia, CanadaDirectorRoger Richer · Vancouver, British Columbia, CanadaDirectorFrancis Macdonald · Vancouver, British Columbia, CanadaExec · DirectorBhavik M. Patel · Miami, FLDirectorKeli M. Callaghan · Miami, FLDirectorTaryn M. Naidu · Miami, FLExecVishaal Turakhia · San Diego, CAExecChris Krueger · San Francisco, CAExecEnoch Kariuki · San Diego, CAExecKaran C. Takhar · San Diego, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗